| 原发性肝癌分子靶向治疗临床研究进展 |
| |
| 引用本文： | 高嵩,杨仁杰. 原发性肝癌分子靶向治疗临床研究进展[J]. 肿瘤研究与临床, 2008, 20(8): 570-574 |
| |
| 作者姓名： | 高嵩 杨仁杰 |
| |
| 作者单位： | 北京肿瘤医院暨北京肿瘤防治研究所介入治疗科,北京大学临床肿瘤学院,100142 |
| |
| 摘 要： | 随着分子生物学技术的发展,分子靶向治疗已成为21世纪肿瘤治疗的主要方向和潮流.针对VEGF/VEGFR、EGFR、Raf-MAPK-ERIC、HGFR等靶点的分子靶向治疗以及与其他治疗的联合治疗开始用于原发性肝癌的临床,并在一些临床试验中取得了令人鼓舞的结果.针对原发性肝癌的分子靶向治疗的临床研究进展进行综述.
|
| 关 键 词： | 肝肿瘤 治疗 生物医学研究 |
| 收稿时间： | 2008-04-07 |
Clinical research progress on molecularly targeted therapy of primary hepatic carcinoma |
| |
| GAO Song,YANG Ren-jie. Clinical research progress on molecularly targeted therapy of primary hepatic carcinoma[J]. Cancer Research and Clinic, 2008, 20(8): 570-574 |
| |
| Authors: | GAO Song YANG Ren-jie |
| |
| Affiliation: | GAO Song YANG Ren-jie |
| |
| Abstract: | With the development of molecular biology,molecular targeted therapy has become main direction and trend at the aspect of oneotherapy in the 21th century.Molecularly targeted agents which target VEGF/VEGFR,EGFR.Raf/MAPK-ERIC,HGFR,as well as associating with other therapies are available in the clinical treatment of primary hepatic carcinoma,and inspiring results have also achieved in some clinical trials.The review attempts to summarize the clinical research advancemem in molecularly targeted therapy of primary hepatic carcinoma. |
| |
| Keywords: | Liver neoplasms Therapy Biomedical research |
| 本文献已被 维普 万方数据 等数据库收录！ |
| 点击此处可从《肿瘤研究与临床》浏览原始摘要信息 |
|
点击此处可从《肿瘤研究与临床》下载全文 |
|
